BusinessUnum Therapeutics Announces Closing of Initial Public Offering and Concurrent Private Placement with Seattle GeneticsBy Nasdaq OMXApr 3, 2018, 9:00 PM UTC
BusinessUnum Therapeutics Announces Pricing of Initial Public OfferingBy Nasdaq OMXMar 29, 2018, 1:35 AM UTC
BusinessNkarta Therapeutics Appoints Veteran Executive Paul Hastings as CEO to Lead Next Phase of GrowthBy Nasdaq OMXMar 1, 2018, 7:05 PM UTC
BusinessHeat Biologics to Present at Biotech Showcase 2017 Conference in San FranciscoBy Nasdaq OMXJan 5, 2017, 1:01 PM UTC
BusinessHeat Biologics to Present at Biotech Showcase 2017 Conference in San FranciscoBy Nasdaq OMXJan 5, 2017, 1:01 PM UTC
